ACTU
ACTUATE THERAPEUTICS, INC.
+0.03 (+3.31%)1.03USD113K成交股數24.7M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 2.1M | 2.6M | 2.1M | 2.2M | 2.8M | 3.2M | 3.8M | 4.4M | 6.9M | – | 5.8M | 4.8M |
| 銷售管理費用 | 2.8M | 3.1M | 2.6M | 3.3M | 3.2M | 3.1M | 1.6M | 1.1M | 913K | – | 714K | 807K |
| 營業利益 | −4.9M-18% | −5.7M-10% | −4.7M-13% | −5.5M+1% | −6.0M-23% | −6.4M | −5.4M-17% | −5.4M-3% | −7.8M | – | −6.5M | −5.6M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −4.9M-18% | −5.6M-11% | −4.6M-24% | −5.4M-18% | −5.9M-28% | −6.3M-17% | −6.0M-6% | −6.6M+19% | −8.3M | −7.6M | −6.3M | −5.5M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.20-33% | -0.24-25% | -0.19-65% | -0.25-94% | -0.30-94% | -0.32 | -0.55-87% | -4.20+8% | -5.40 | – | -4.31 | -3.88 |
| 稀釋股數 | 23.9M | 23.5M | 21.0M | 21.4M | 19.6M | 19.5M | 10.8M | 1.6M | 1.5M | 1.4M | 1.5M | 1.4M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 4.4M | 8.1M | 13.2M | 16.9M | 6.5M | 3.9M | 13.5M | 352K | 2.1M | 3.0M | 8.5M | 14.1M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 5.2M | 8.9M | 14.0M | 17.7M | 7.0M | 4.5M | 14.3M | 1.7M | – | 3.0M | – | – |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 4.2M | 5.1M | 6.1M | 6.8M | 9.6M | 9.6M | 8.9M | 21.8M | – | 8.4M | – | – |
| 股東權益 | 989K | 3.8M | 7.9M | 10.9M | −2.7M | −5.1M | 5.4M | −114M | −108M | −99.6M | −92.1M | −86.0M |
| 負債比 | 81.0% | 57.5% | 43.5% | 38.3% | 138.1% | 213.5% | 62.4% | 1,260.0% | – | 281.9% | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −5.0M+9% | – | – | – | −4.6M | – | – | −5.2M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −22.2M | –% | -1.06 | – |
| FY2024 | – | – | −27.3M | –% | -3.26 | – |
| FY2023 | – | – | −24.7M | –% | -17.24 | – |